{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:12:12Z","timestamp":1790856732993,"version":"4.1.0"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>Retinoblastoma is a retinal cancer that affects children and is the most prevalent intraocular tumor worldwide. Despite tremendous breakthroughs in our understanding of the fundamental mechanisms that regulate progression of retinoblastoma, the development of targeted therapeutics for retinoblastoma has lagged. Our review highlights the current developments in the genetic, epigenetic, transcriptomic, and proteomic landscapes of retinoblastoma. We also discuss their clinical relevance and potential implications for future therapeutic development, with the aim to create a frontline multimodal therapy for retinoblastoma.<\/jats:p>","DOI":"10.4103\/ijo.ijo_3172_22","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T14:01:08Z","timestamp":1688565668000},"page":"2662-2676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies"],"prefix":"10.4103","volume":"71","author":[{"given":"Shruti","family":"Rathore","sequence":"first","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Verma","sequence":"additional","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Ratna","sequence":"additional","affiliation":[{"name":"Ocular Genetics Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navjot","family":"Marwa","sequence":"additional","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagya","family":"Ghiya","sequence":"additional","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh G","family":"Honavar","sequence":"additional","affiliation":[{"name":"Ophthalmic Plastic Surgery, Orbit and Ocular Oncology, Centre for Sight, Hyderbad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Das","sequence":"additional","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Varshney","sequence":"additional","affiliation":[{"name":"Ocular Oncology Services, Dr. Shroff\u2019s Charity Eye Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamaoncol.2019.6716","article-title":"Global retinoblastoma presentation and analysis by national income level","volume":"6","author":"Group","year":"2020","journal-title":"JAMA Oncol"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"25264","DOI":"10.1038\/srep25264","article-title":"Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes","volume":"6","author":"Kooi","year":"2016","journal-title":"Sci Rep"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4274\/tjo.06888","article-title":"Chemotherapy in retinoblastoma: Current approaches","volume":"45","author":"Yan\u0131k","year":"2015","journal-title":"Turk J Ophthalmol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/ijo.IJO_883_16","article-title":"Recent advances and challenges in the management of retinoblastoma","volume":"65","author":"Chawla","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/sj.onc.1209622","article-title":"Diagnosis and current management of retinoblastoma","volume":"25","author":"Balmer","year":"2006","journal-title":"Oncogene"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00006982-200412000-00003","article-title":"Continuing challenges in the management of retinoblastoma with chemotherapy","volume":"24","author":"Shields","year":"2004","journal-title":"Retina"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front Pharmacol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: Statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(78)90277-5","article-title":"Segregation of chromosome 13 in retinoblastoma","volume":"311","author":"Knight","year":"1978","journal-title":"Lancet"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/309458a0","article-title":"Expression and amplification of the N-myc gene in primary retinoblastoma","volume":"309","author":"Lee","year":"1984","journal-title":"Nature"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/323643a0","article-title":"A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma","volume":"323","author":"Friend","year":"1986","journal-title":"Nature"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-4608(01)00427-7","article-title":"Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization","volume":"129","author":"Chen","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1038\/sj.onc.1208792","article-title":"Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma","volume":"24","author":"Grasemann","year":"2005","journal-title":"Oncogene"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/gcc.20457","article-title":"One hit, two hits, three hits, more?Genomic changes in the development of retinoblastoma","volume":"46","author":"Corson","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/hmg\/ddn024","article-title":"Loss of RB1 induces non-proliferative retinoma: Increasing genomic instability correlates with progression to retinoblastoma","volume":"17","author":"Dimaras","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"438","DOI":"10.18632\/oncotarget.1686","article-title":"RB1 gene inactivation by chromothripsis in human retinoblastoma","volume":"5","author":"McEvoy","year":"2014","journal-title":"Oncotarget"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"e0153323","DOI":"10.1371\/journal.pone.0153323","article-title":"A meta-analysis of retinoblastoma copy numbers refines the list of possible driver genes involved in tumor progression","volume":"11","author":"Kooi","year":"2016","journal-title":"PLoS One"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3934\/mbe.2021017","article-title":"Identification of driver genes with aberrantly alternative splicing events in pediatric patients with retinoblastoma","volume":"18","author":"Yang","year":"2020","journal-title":"Math Biosci Eng"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/cancers13010149","article-title":"Molecular changes in retinoblastoma beyond RB1: Findings from next-generation sequencing","volume":"13","author":"Francis","year":"2021","journal-title":"Cancers"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fgene.2018.00170","article-title":"RNA-sequencing of primary retinoblastoma tumors provides new insights and challenges into tumor development","volume":"9","author":"Elchuri","year":"2018","journal-title":"Front Genet"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s004390000450","article-title":"Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization","volume":"108","author":"Herzog","year":"2001","journal-title":"Hum Genet"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1167\/iovs.07-0063","article-title":"High expression of KIF14 in retinoblastoma: Association with older age at diagnosis","volume":"48","author":"Madhavan","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/onc.2016.350","article-title":"MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation","volume":"36","author":"Qi","year":"2017","journal-title":"Oncogene"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"1000677","DOI":"10.3389\/fonc.2022.1000677","article-title":"MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma","volume":"12","author":"Romani","year":"2022","journal-title":"Front Oncol"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41419-021-04390-4","article-title":"Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3892\/ijo.2015.3179","article-title":"OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways","volume":"47","author":"Li","year":"2015","journal-title":"Int J Oncol"},{"key":"R28-20240828","first-page":"1360","article-title":"Downregulation of NIMA-related kinase-7 inhibits cell proliferation by inducing cell cycle arrest in human retinoblastoma cells","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jcb.29177","article-title":"SKP2, positively regulated by circ_ODC1\/miR-422a axis, promotes the proliferation of retinoblastoma","volume":"121","author":"Du","year":"2020","journal-title":"J Cell Biochem"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41420-020-0237-8","article-title":"Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy","volume":"6","author":"Aubry","year":"2020","journal-title":"Cell Death Discovery"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1128\/MCB.00374-09","article-title":"Changes in retinoblastoma cell adhesion associated with optic nerve invasion","volume":"29","author":"Laurie","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12886-020-01348-6","article-title":"Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism","volume":"20","author":"Song","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","article-title":"Caspase functions in cell death and disease","volume":"5","author":"McIlwain","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1167\/iovs.06-1147","article-title":"The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro","volume":"48","author":"Poulaki","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"745187","DOI":"10.3389\/fonc.2021.745187","article-title":"The role of ARID1A in tumors: Tumor initiation or tumor suppression?","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1038\/s41467-021-25792-0","article-title":"A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer discovery"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2019.00221","article-title":"Non-coding and coding transcriptional profiles are significantly altered in pediatric retinoblastoma tumors","volume":"9","author":"Rajasekaran","year":"2019","journal-title":"Front Oncol"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"108067","DOI":"10.1016\/j.exer.2020.108067","article-title":"Gene expression profiling of tumor stroma interactions in retinoblastoma","volume":"197","author":"Raguraman","year":"2020","journal-title":"Exp Eye Res"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00432-020-03266-y","article-title":"Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis","volume":"146","author":"Alvarez-Suarez","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12014-016-9128-7","article-title":"Proteomic profiling of retinoblastoma by high resolution mass spectrometry","volume":"13","author":"Danda","year":"2016","journal-title":"Clin Proteomics"},{"key":"R42-20240828","first-page":"2821","article-title":"Driver gene SOX4 in retinoblastoma","volume":"61","author":"Zeitouni","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"10185","DOI":"10.1038\/s41598-020-67101-7","article-title":"Clinical relevance of B7H3 expression in retinoblastoma","volume":"10","author":"Ganesan","year":"2020","journal-title":"Sci Rep"},{"key":"R44-20240828","first-page":"8084","article-title":"iTRAQ-based quantitative proteomic analysis and bioinformatics study of proteins in retinoblastoma","volume":"14","author":"Cheng","year":"2017","journal-title":"Oncol Lett"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1038\/mtna.2016.70","article-title":"Nucleolin-aptamer therapy in retinoblastoma: Molecular changes and mass spectrometry-based imaging","volume":"5","author":"Subramanian","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1167\/iovs.04-1022","article-title":"Cyclosporin a inhibits calcineurin\/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells","volume":"46","author":"Eckstein","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-07-4836","article-title":"Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma","volume":"14","author":"Dalgard","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1158\/1078-0432.CCR-07-0791","article-title":"Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies","volume":"13","author":"Kummar","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CMR.0b013e328307c248","article-title":"Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma","volume":"18","author":"Hauschild","year":"2008","journal-title":"Melanoma Res"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/cancers12061555","article-title":"Proteomic profiling of retinoblastoma-derived exosomes reveals potential biomarkers of vitreous seeding","volume":"12","author":"Galardi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jprot.2017.02.006","article-title":"Identification of differentially expressed proteins in retinoblastoma tumors using mass spectrometry-based comparative proteomic approach","volume":"159","author":"Naru","year":"2017","journal-title":"J Proteomics"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/prca.200900069","article-title":"Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors","volume":"4","author":"Mallikarjuna","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature10733","article-title":"A novel retinoblastoma therapy from genomic and epigenetic analyses","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3892\/ol.2020.11613","article-title":"High levels of global genome methylation in patients with retinoblastoma","volume":"20","author":"Yazici","year":"2020","journal-title":"Oncol Lett"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1309\/AJCPHGQ69FXDFWII","article-title":"Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis","volume":"134","author":"Qu","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1593\/neo.04565","article-title":"Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma","volume":"7","author":"Choy","year":"2005","journal-title":"Neoplasia"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.21873\/anticanres.14499","article-title":"Inhibition of retinoblastoma cell growth by CEP1347 through activation of the P53 pathway","volume":"40","author":"Togashi","year":"2020","journal-title":"Anticancer Res"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41389-020-0210-7","article-title":"Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression","volume":"9","author":"Zocchi","year":"2020","journal-title":"Oncogenesis"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3727\/096504021X16130322409507","article-title":"Therapeutic targeting PLK1 by ON-01910. Na is effective in local treatment of retinoblastoma","volume":"28","author":"Ma","year":"2021","journal-title":"Oncol Res"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.62.15.11","article-title":"Xanthatin selectively targets retinoblastoma by inhibiting the PLK1-mediated cell cycle","volume":"62","author":"Yang","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000447300","article-title":"Targeting HMGA2 in retinoblastoma cells in vitro using the aptamer strategy","volume":"2","author":"Nalini","year":"2016","journal-title":"Ocul Oncol Pathol"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"11747","DOI":"10.1038\/s41598-018-29938-x","article-title":"Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage","volume":"8","author":"Xiong","year":"2018","journal-title":"Sci Rep"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12253-012-9498-8","article-title":"Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA","volume":"18","author":"Livide","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"e23314","DOI":"10.1097\/MD.0000000000023314","article-title":"Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma","volume":"99","author":"Zeng","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/molecules23061454","article-title":"Phosphoproteomics of retinoblastoma: A pilot study identifies aberrant kinases","volume":"23","author":"Selvan","year":"2018","journal-title":"Molecules"},{"key":"R66-20240828","first-page":"704","article-title":"[The retinoblastoma gene: Will therapeutic use of its tumor suppressive properties be possible?","volume":"80","author":"Bignon","year":"1993","journal-title":"Bull Cancer"},{"key":"R67-20240828","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaophthalmol.2020.0427","article-title":"Genomic and transcriptomic tumor heterogeneity in bilateral retinoblastoma","volume":"138","author":"Winter","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yexcr.2018.12.018","article-title":"Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines","volume":"375","author":"Schwermer","year":"2019","journal-title":"Exp Cell Res"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"160008","DOI":"10.1038\/sdata.2016.8","article-title":"Transcriptome regulation and chromatin occupancy by E2F3 and MYC in mice","volume":"3","author":"Tang","year":"2016","journal-title":"Sci Data"},{"key":"R70-20240828","doi-asserted-by":"crossref","first-page":"e42739","DOI":"10.1371\/journal.pone.0042739","article-title":"Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma","volume":"7","author":"McEvoy","year":"2012","journal-title":"PLoS One"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/1541-7786.495.2.9","article-title":"Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma","volume":"2","author":"Marchong","year":"2004","journal-title":"Mol Cancer Res"},{"key":"R72-20240828","first-page":"1344","article-title":"Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues","volume":"43","author":"Choy","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R73-20240828","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1038\/sj.onc.1205446","article-title":"Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines","volume":"21","author":"Harada","year":"2002","journal-title":"Oncogene"},{"key":"R74-20240828","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/hmg\/ddn024","article-title":"Loss of RB1 induces non-proliferative retinoma: Increasing genomic instability correlates with progression to retinoblastoma","volume":"17","author":"Dimaras","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R75-20240828","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.2013.283","article-title":"Gene expression profiling identifies different sub-types of retinoblastoma","volume":"109","author":"Kapatai","year":"2013","journal-title":"Br J Cancer"},{"key":"R76-20240828","doi-asserted-by":"crossref","first-page":"1700101","DOI":"10.1002\/prca.201700101","article-title":"Membrane proteome of invasive retinoblastoma: Differential proteins and biomarkers","volume":"12","author":"Danda","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"R77-20240828","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1093\/hmg\/ddu114","article-title":"Comprehensive analysis of gene expression in human retina and supporting tissues","volume":"23","author":"Li","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R78-20240828","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"R79-20240828","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-16-3299","article-title":"SKP2 activation by thyroid hormone receptor b2 bypasses Rb-dependent proliferation in Rb-deficient cells","volume":"77","author":"Xu","year":"2017","journal-title":"Cancer Res"},{"key":"R80-20240828","first-page":"850","article-title":"Pharmacologic targeting of Skp2 in retinoblastoma","volume":"55","author":"Xu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R81-20240828","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/s41388-020-1372-7","article-title":"Functional genomics identifies new synergistic therapies for retinoblastoma","volume":"39","author":"Aubry","year":"2020","journal-title":"Oncogene"},{"key":"R82-20240828","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archopht.124.9.1269","article-title":"Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells","volume":"124","author":"Elison","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R83-20240828","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3727\/096504021X16130322409507","article-title":"Therapeutic targeting PLK1 by ON-01910. Na is effective in local treatment of retinoblastoma","volume":"28","author":"Ma","year":"2021","journal-title":"Oncol Res"},{"key":"R84-20240828","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1038\/mtna.2016.70","article-title":"Nucleolin-aptamer therapy in retinoblastoma: Molecular changes and mass spectrometry-based imaging","volume":"5","author":"Subramanian","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"R85-20240828","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/nat.2014.0507","article-title":"Blocking the maturation of OncomiRNAs using pri-miRNA-17 ~92 aptamer in retinoblastoma","volume":"25","author":"Subramanian","year":"2015","journal-title":"Nucleic Acid Ther"},{"key":"R86-20240828","doi-asserted-by":"crossref","first-page":"32115","DOI":"10.1039\/C5RA27072C","article-title":"Targeting CD44, ABCG2 and CD133 markers using aptamers: In silico analysis of CD133 extracellular domain 2 and its aptamer","volume":"6","author":"Subramanian","year":"2016","journal-title":"RSC Adv"},{"key":"R87-20240828","first-page":"2783","article-title":"Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer","volume":"18","author":"Subramanian","year":"2012","journal-title":"Mol Vis"},{"key":"R88-20240828","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1039\/D0SC01613F","article-title":"A highly stable RNA aptamer probe for the retinoblastoma protein in live cells","volume":"11","author":"Le","year":"2020","journal-title":"Chem Sci"},{"key":"R89-20240828","doi-asserted-by":"crossref","first-page":"eaat9321","DOI":"10.1126\/scitranslmed.aat9321","article-title":"Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01","volume":"11","author":"Pascual-Pasto","year":"2019","journal-title":"Sci Transl Med"},{"key":"R90-20240828","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1186\/s12885-019-6131-1","article-title":"CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing","volume":"19","author":"Andersch","year":"2019","journal-title":"BMC Cancer"},{"key":"R91-20240828","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","article-title":"GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision","volume":"1","author":"Wang","year":"2020","journal-title":"Nature Cancer"},{"key":"R92-20240828","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1038\/s41467-021-24781-7","article-title":"Retinoblastoma from human stem cell-derived retinal organoids","volume":"12","author":"Norrie","year":"2021","journal-title":"Nat Commun"},{"key":"R93-20240828","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MPH.0000000000001955","article-title":"Haploidentical hematopoietic stem cell transplantation for relapsed metastatic retinoblastoma","volume":"42","author":"Rastogi","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R94-20240828","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/APO.0000000000000372","article-title":"Stem-cell therapy following high-dose chemotherapy in advanced retinoblastoma: A systematic review","volume":"10","author":"Clarissa","year":"2021","journal-title":"Asia Pac J Ophthalmol"},{"key":"R95-20240828","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtn.2017.10.012","article-title":"Characterization and molecular mechanism of peptide-conjugated gold nanoparticle inhibiting p53-HDM2 interaction in retinoblastoma","volume":"9","author":"Kalmodia","year":"2017","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_3172_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:51Z","timestamp":1787760651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_3172_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_3172_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}